EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement

Joseph Rabbat, Boyu Yang, Hye Won Lee, Huapeng Lin, Emmanuel Tsochatzis, Salvatore Petta, Elisabetta Bugianesi, Masato Yoneda, Ming-Hua Zheng, Hannes Hagström, Jérôme Boursier, José Luis Calleja und 29 weitere

Clinical and Molecular Hepatology · 01.01.2026 · 32 (1) · 289-304

DOI: 10.3350/cmh.2025.0888 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 01.01.2026. Verfasst von Joseph Rabbat und 40 weiteren Autor:innen. Beteiligte Einrichtung: Medical Data Analytics Centre, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Liver, Liver Cirrhosis, Fatty Liver. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project of China, Hong Kong SAR Government, Direct Grant of The Chinese University of Hong Kong.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Current guidelines recommend a 2-step approach for identifying advanced fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD), using Fibrosis-4 index (FIB-4) followed by liver stiffness measurement (LSM) via vibration-controlled transient elastography (VCTE). However, some patients may exhibit discordant results. This study evaluates the histological severity and outcomes in patients with discordant FIB-4 and LSM results.

Methods

This secondary analysis of the VCTE-Prognosis study included 12,950 patients evaluated for MASLD at 16 tertiary centers, of whom 2,915 underwent liver biopsy. Patients were categorized into four groups based on established FIB-4 (1.3) and LSM (8 kPa) cutoffs.

Results

F3–F4 fibrosis was observed in 6.4%, 13.7%, 30.6%, and 62.4% in low-FIB-4-low-LSM (n=6,403), high-FIB-4-low-LSM (n=3,017), low-FIB-4-high-LSM (n=1,363), and high-FIB-4-high-LSM (n=2,167) groups, respectively. During a median follow-up of 47.4 months, 248 patients experienced hepatic decompensation, hepatocellular carcinoma, liver transplantation, or liver-related death. The incidence rates of liver-related events (LREs) were 0.67, 1.19, 2.58, and 21.30 per 1,000 person-years, respectively. Compared to low-FIB-4-low-LSM patients, those with low-FIB-4-high-LSM (adjusted subdistribution hazard ratio [aSHR] 4.12) and high-FIB-4-high-LSM (aSHR 21.38) had a significantly higher risk of LREs, while high-FIB-4-low-LSM patients did not. Similar findings were observed when hepatic decompensation and hepatocellular carcinoma were analyzed separately.

Conclusions

Approximately 30% of patients in tertiary centers exhibit discordant FIB-4 and LSM results, with LSM more likely reflecting true severity. While some patients with discordant results may have advanced fibrosis, the overall incidence of LREs remains low.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiverLiver CirrhosisFatty LiverHumansFemaleMaleMiddle AgedElasticity Imaging TechniquesSeverity of Illness IndexAdultBiopsyAgedPrognosisLiver Neoplasms

Stichwörter der Autor:innen

Liver cirrhosisLiver fibrosisMetabolic dysfunction-associated steatotic liver diseaseSteatotic liver disease

Autor:innen und Institutionen

  • Medical Data Analytics Centre, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
  • State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.
  • Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Gastroenterology and Hepatology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • University College London Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, United Kingdom.
  • Section of Gastroenterology, PROMISE, University of Palermo, Italy.

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project of China
  • Hong Kong SAR Government
  • Direct Grant of The Chinese University of Hong Kong
  • D3 4 Health - Digital DrivenDiagnostics, prognostics and therapeutics for sustainable Health care
  • Gilead Sciences
  • Kowa Company
  • Mochida Pharmaceutical Company
  • Astellas Pharma

Zitieren

APA

Rabbat, J., Yang, B., Lee, H. W., Lin, H., Tsochatzis, E., Petta, S., Bugianesi, E., Yoneda, M., Zheng, M. H., Hagström, H., Boursier, J., Calleja, J. L., Goh, G. B., Chan, W. K., Gallego-Durán, R., Sanyal, A. J., Lédinghen, V., Newsome, P. N., Fan, J. G., …, & Yip, T. C. (2026). Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement. Clinical and Molecular Hepatology, 32(1), 289-304. https://doi.org/10.3350/cmh.2025.0888

Vancouver

Rabbat J, Yang B, Lee HW, Lin H, Tsochatzis E, Petta S, et al. Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement. Clinical and Molecular Hepatology. 2026;32(1):289-304. doi:10.3350/cmh.2025.0888

BibTeX
@article{Rabbat2026,
  author = {Rabbat, Joseph and Yang, Boyu and Lee, Hye Won and Lin, Huapeng and Tsochatzis, Emmanuel and Petta, Salvatore and Bugianesi, Elisabetta and Yoneda, Masato and Zheng, Ming-Hua and Hagström, Hannes and Boursier, Jérôme and Calleja, José Luis and Goh, George Boon-Bee and Chan, Wah-Kheong and Gallego-Durán, Rocio and Sanyal, Arun J and Lédinghen, Victor de and Newsome, Philip N and Fan, Jian-Gao and Castéra, Laurent and Lai, Michelle and Fournier-Poizat, Céline and Wong, Grace Lai-Hung and Zoncape, Mirko and Pennisi, Grazia and Armandi, Angelo and Nakajima, Atsushi and Liu, Wen-Yue and Shang, Ying and Saint-Loup, Marc de and Llop, Elba and Teh, Kevin Kim Jun and Lara-Romero, Carmen and Asgharpour, Amon and Mahgoub, Sara and Chan, Mandy Sau-Wai and Canivet, Clemence M and Romero-Gomez, Manuel and Wong, Vincent Wai-Sun and Kim, Seung Up and Yip, Terry Cheuk-Fung},
  title = {Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  volume = {32},
  number = {1},
  pages = {289--304},
  doi = {10.3350/cmh.2025.0888}
}
Kostenlos starten →